US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.6210
  • -0.0230-3.57%
Trading Apr 30 12:46 ET
3.16MMarket Cap-0.12P/E (TTM)

About Matinas BioPharma Company

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Company Profile

SymbolMTNB
Company NameMatinas BioPharma
Listing DateMar 2, 2017
Founded2013
CEOMr. Jerome D. Jabbour, J.D.
MarketAMEX
Employees3
Fiscal Year Ends12-31
Address1545 Route 206 South,Suite 302
CityBedminster
ProvinceNew Jersey
CountryUnited States of America
Zip Code07921-9999
Phone1-908-484-8805

Company Executives

  • Name
  • Position
  • Salary
  • Jerome D. Jabbour, J.D.
  • Chief Executive Officer, President and Chairman of the Board
  • 598.00K
  • Keith A. Kucinski, C.P.A.,M.B.A.
  • Chief Financial Officer and Principal Accounting Officer
  • 584.16K
  • Evelyn D’An
  • Independent Director
  • --
  • Dr. Robin L. Smith, M.B.A.,M.D.
  • Independent Director
  • --
  • Keith Murphy
  • Independent Director
  • --
  • Edward Neugeboren
  • Independent Director
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More